Stock Report

Download full stock data and analysis for free Last Updated: 01-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Sai Parenteral’s Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: SAIPARENT | BSE: 544742

₹520.20

up-down-arrow ₹-1.15 (-0.22%)

As on 31-Aug-2026IST

Market cap

info icon

₹2,296 Cr

Revenue (TTM)

info icon

₹381 Cr

P/E Ratio

info icon

139.1

P/B Ratio

info icon

2.9

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -9.73 435.09 133.59 57.89 --
EBIT -13.97 367.76 -34.26 17.17 --
Net Profit -39.78 460.25 -1.16 48.25 --
EPS -39.78 237.34 -29.98 6.88 --
Book Value -- -- 215.67 71.52 --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsMar-26Mar-25Mar-24
EBIT-Margin info 12.97--5.3819.1214.42
Net Margin info 5.96--3.658.815.42
Return on equity info 12.64--4.8817.1515.87
Return on Capital info 12.98--6.1016.7016.14
Return on Assets info 3.74--1.695.354.19
Debt to Equity (x) info ----0.651.001.59

Profitability

View Detailed Peer Comparison

ROCE

6.10

Lower than Peers by 9.38

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sai Parenteral’s
6.10
16.70
16.14
12.97
--
Peer Median
15.48
16.46
15.49
17.37
--
ROE

4.88

Lower than Peers by 7.80

Profit after tax / Average Net worth * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sai Parenteral’s
4.88
17.15
15.87
13.90
--
Peer Median
12.68
13.87
14.72
15.70
--
ROA

1.69

Lower than Peers by 6.00

Profit after tax / Average Total assets * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sai Parenteral’s
1.69
5.35
4.19
3.27
--
Peer Median
7.69
8.04
7.19
9.43
--
EBIT Margin

5.38

Lower than Peers by 10.30

Operating profit (EBIT) / Net Sales * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sai Parenteral’s
5.38
19.12
14.42
13.16
--
Peer Median
15.68
10.05
10.28
13.90
--
Net Margin

3.65

Lower than Peers by 7.52

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sai Parenteral’s
3.65
8.81
5.42
4.51
--
Peer Median
11.16
9.11
6.78
10.91
--
Cash Profit Margin

8.17

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sai Parenteral’s
8.17
13.88
11.60
10.51
--
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

Revenue Growth

133.59

Higher than Peers by 118.54

Year on year growth in net sales

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sai Parenteral’s
133.59
6.08
58.85
--
--
Peer Median
15.05
7.17
10.56
12.63
--
EBIT Growth

-34.26

Lower than Peers by 54.14

Year on year growth in operating profit (EBIT)

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sai Parenteral’s
-34.26
40.66
73.96
--
--
Peer Median
19.88
12.05
6.17
-2.90
--
Net Profit Growth

-1.16

Lower than Peers by 20.28

Year on year growth in profit after tax

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sai Parenteral’s
-1.16
71.44
92.30
--
--
Peer Median
19.11
22.15
27.97
-14.10
--
EPS Growth

-29.98

Lower than Peers by 53.09

Year on year growth in earnings per share

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sai Parenteral’s
-29.98
59.09
9.60
--
--
Peer Median
23.11
8.80
--
-3.68
--
Book Value Growth

423.95

--

Year on year growth in book value per share

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sai Parenteral’s
423.95
25.65
136.76
--
--
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

0.65

Higher than Peers by 0.53

Total debt / Net worth

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sai Parenteral’s
0.65
1.00
1.59
2.18
--
Peer Median
0.12
0.03
0.05
0.14
--
Short term debt to equity ratio

0.45

--

(Short term borrowings / Net worth)

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sai Parenteral’s
0.45
0.78
0.96
1.11
--
Peer Median
--
--
--
--
--
Current Ratio

1.44

Lower than Peers by 1.04

Current Assets / Current Liabilities and Provisions

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sai Parenteral’s
1.44
1.23
1.23
1.07
--
Peer Median
2.48
2.20
1.93
1.82
--
Quick Ratio

1.14

Lower than Peers by 0.68

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sai Parenteral’s
1.14
0.92
0.98
0.90
--
Peer Median
1.82
1.72
1.59
1.30
--
Interest Coverage

1.64

Lower than Peers by 12.03

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sai Parenteral’s
1.64
2.67
2.13
2.27
--
Peer Median
13.67
12.28
12.45
16.98
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

47.52

Higher than Peers by 16.87

Debtors outstanding / Net Sales * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sai Parenteral’s
47.52
77.60
82.64
63.23
--
Peer Median
30.65
26.23
23.97
24.57
--
Asset Turnover

0.45

Lower than Peers by 0.25

Sales / Average Total Assets

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sai Parenteral’s
0.45
0.60
0.77
0.72
--
Peer Median
0.70
0.74
0.88
0.82
--
Receivable days

147.34

--

Average Debtors / Sales * 365

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sai Parenteral’s
147.34
283.79
223.46
230.80
--
Peer Median
--
--
--
--
--
Inventory Days

106.77

--

Average Inventory / Sales * 365

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sai Parenteral’s
106.77
98.78
59.82
49.73
--
Peer Median
--
--
--
--
--
Payable days

155.63

--

Average Creditors / Cost of goods sold * 365

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sai Parenteral’s
155.63
215.25
144.13
140.32
--
Peer Median
--
--
--
--
--
Cash Conversion Cycle

98.48

--

Receivable Days + Inventory Days - Payable Days

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sai Parenteral’s
98.48
167.32
139.15
140.22
--
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sai Parenteral’s
--
--
--
--
--
Peer Median
55.08
39.17
40.74
25.97
--
Price / Book Value

--

--

Current share price divided by book value per share in the latest financial year

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sai Parenteral’s
--
--
--
--
--
Peer Median
4.88
3.61
3.87
2.79
--
EV/EBITDA

-1.59

Lower than Peers by 43.68

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sai Parenteral’s
-1.59
2.63
3.86
4.02
--
Peer Median
42.08
28.79
25.41
15.07
--
Market Cap

--

--

Current Share price multiplied by latest total number of shares outstanding

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sai Parenteral’s
--
--
--
--
--
Peer Median
5,782
3,944
2,959
3,742
--
loading...
loading...
loading...
loading...
loading...